A

Avalon Globocare Corp
NASDAQ:ALBT

Watchlist Manager
Avalon Globocare Corp
NASDAQ:ALBT
Watchlist
Price: 1.71 USD 23.91% Market Closed
Market Cap: 7.3m USD

Avalon Globocare Corp
Additional Paid In Capital

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Avalon Globocare Corp
Additional Paid In Capital Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Additional Paid In Capital CAGR 3Y CAGR 5Y CAGR 10Y
A
Avalon Globocare Corp
NASDAQ:ALBT
Additional Paid In Capital
$87.5m
CAGR 3-Years
10%
CAGR 5-Years
14%
CAGR 10-Years
N/A
Quest Diagnostics Inc
NYSE:DGX
Additional Paid In Capital
$2.4B
CAGR 3-Years
1%
CAGR 5-Years
-3%
CAGR 10-Years
0%
CVS Health Corp
NYSE:CVS
Additional Paid In Capital
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Cigna Corp
NYSE:CI
Additional Paid In Capital
$31.7B
CAGR 3-Years
3%
CAGR 5-Years
2%
CAGR 10-Years
27%
Laboratory Corporation of America Holdings
NYSE:LH
Additional Paid In Capital
$33m
CAGR 3-Years
N/A
CAGR 5-Years
-16%
CAGR 10-Years
-33%
Guardant Health Inc
NASDAQ:GH
Additional Paid In Capital
$2.6B
CAGR 3-Years
14%
CAGR 5-Years
10%
CAGR 10-Years
N/A
No Stocks Found

Avalon Globocare Corp
Glance View

Market Cap
7m USD
Industry
Health Care

Avalon GloboCare Corp. is a holding company, which engages in the development of biotechnology and the provision of healthcare services. The company is headquartered in Freehold, New Jersey and currently employs 5 full-time employees. The company went IPO on 2016-02-22. The firm is focused on the fields of cellular immunotherapy, including CAR-T/NK; exosome technology (ACTEX), and COVID-19-related vaccine and therapeutics through its subsidiaries. The company operates through two business segments: real property operating segment and medical related consulting services segment. The firm also provides strategic advisory and outsourcing services to facilitate and improve its clients’ growth and development, as well as competitiveness in healthcare and CellTech industry markets. Its downstream medical team and facility consists of affiliated hospital networks and experts specialized in hematology, oncology, cellular immunotherapy, hematopoietic stem/progenitor cell transplant, as well as regenerative therapeutics. Its clinical programs include AVA-001, ACTEX, FLASH-CAR, and AVA-Trap.

ALBT Intrinsic Value
HIDDEN
Show

See Also

What is Avalon Globocare Corp's Additional Paid In Capital?
Additional Paid In Capital
87.5m USD

Based on the financial report for Sep 30, 2025, Avalon Globocare Corp's Additional Paid In Capital amounts to 87.5m USD.

What is Avalon Globocare Corp's Additional Paid In Capital growth rate?
Additional Paid In Capital CAGR 5Y
14%

Over the last year, the Additional Paid In Capital growth was 23%. The average annual Additional Paid In Capital growth rates for Avalon Globocare Corp have been 10% over the past three years , 14% over the past five years .

Back to Top